Pacific Biosciences
PACB
#6557
Rank
ยฃ0.54 B
Marketcap
ยฃ1.79
Share price
-5.16%
Change (1 day)
15.61%
Change (1 year)

Pacific Biosciences (PACB) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.57 Billion

According to Pacific Biosciences 's latest financial reports the company's total liabilities are ยฃ0.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.60 B-26.74%
2023-12-31ยฃ0.82 B-17.62%
2022-12-31ยฃ0.99 B10.49%
2021-12-31ยฃ0.90 B1464.42%
2020-12-31ยฃ57.58 M-18.87%
2019-12-31ยฃ70.97 M60.26%
2018-12-31ยฃ44.28 M3.23%
2017-12-31ยฃ42.9 M-0.53%
2016-12-31ยฃ43.12 M11.02%
2015-12-31ยฃ38.84 M-12.9%
2014-12-31ยฃ44.6 M9.8%
2013-12-31ยฃ40.62 M223.41%
2012-12-31ยฃ12.56 M-27.3%
2011-12-31ยฃ17.27 M3.05%
2010-12-31ยฃ16.76 M-90.25%
2009-12-31ยฃ0.17 B22.03%
2008-12-31ยฃ0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Illumina
ILMN
ยฃ2.84 B 394.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
ยฃ0.24 B-57.59%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ81.98 B 14,138.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ38.93 B 6,661.59%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
ยฃ4.95 B 760.98%๐Ÿ‡บ๐Ÿ‡ธ USA